e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Disease exacerbations from a molecular point of view
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Modeling exacerbation using ozone exposure in COPD patients: CO3PD pilot study
M. Arjomandi (San Francisco, United States of America), S. Vasudevan (San Francisco, United States of America), H. Wong (San Francisco, United States of America), S. Dalton (San Francisco, United States of America), S. Zeng (San Francisco, United States of America)
Source:
International Congress 2018 – Disease exacerbations from a molecular point of view
Session:
Disease exacerbations from a molecular point of view
Session type:
Poster Discussion
Number:
4970
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Arjomandi (San Francisco, United States of America), S. Vasudevan (San Francisco, United States of America), H. Wong (San Francisco, United States of America), S. Dalton (San Francisco, United States of America), S. Zeng (San Francisco, United States of America). Modeling exacerbation using ozone exposure in COPD patients: CO3PD pilot study. 4970
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Altered microRNA profiles in the bronchoalveolar lavage fluid exosomes in asthma and COPD
Related content which might interest you:
Acute health effects after passive e-vape among patients with COPD – an RCT exposure study
Source: Virtual Congress 2020 – From tobacco and vaping health effects to tobacco cessation
Year: 2020
A multicentre study of air pollution exposure and childhood asthma prevalence: the ESCAPE project
Source: Eur Respir J 2015; 45: 610-624
Year: 2015
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Characteristics of COPD patients with repeated exacerbations: preliminary results from the PRE-SPIRO survey
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
NIV after acute exacerbation of COPD: results from the Dutch multicentre study
Source: International Congress 2015 – Long-term non-invasive ventilation (NIV) in COPD
Year: 2015
Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
A prediction model for exacerbations in patients with COPD generated in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017
Acute exacerbation of COPD patients therapy priorities: A survey study
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021
Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Impact of chronic cough in individuals with COPD: a population-based cohort study
Source: International Congress 2019 – More and more COPD
Year: 2019
Baseline data and responses to oral steroid intervention in asthma and COPD: interim report from the BIOAIR EU study
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
Analysis of pre-hospital management in hospitalized patients with bronchial asthma (BA) exacerbation: 6-year observational study
Source: Eur Respir J 2006; 28: Suppl. 50, 313s
Year: 2006
Incident case-referent study of asthma: studies of the influence of work-related, indoor-,and outdoor environmental factors on the onset of adult asthma based on incident asthma; study design and first results
Source: Eur Respir J 2002; 20: Suppl. 38, 425s
Year: 2002
Comparative study of hospitalized patients with acute exacerbation of COPD with and without carbon dioxide retention
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS)
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016
The association between cadmium exposure and chronic airflow limitation and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot)
Source: Eur Respir J, 54 (5) 1900960; 10.1183/13993003.00960-2019
Year: 2019
Bacterial profile and antibiotic susceptibility from patients with exacerbation of COPD: 10 – years prospective study
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort
Source: International Congress 2017 – COPD: latest insights into the management of patients
Year: 2017
Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept